{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361418520826378752.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1681/asn.v391575"}},{"identifier":{"@type":"URI","@value":"https://journals.lww.com/00001751-199303000-00006"}}],"dc:title":[{"@value":"Angiotensin-converting enzyme inhibitor fetopathy."}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380016864393734016","@type":"Researcher","foaf:name":[{"@value":"P G Pryde"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418520826378755","@type":"Researcher","foaf:name":[{"@value":"A B Sedman"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418520826378752","@type":"Researcher","foaf:name":[{"@value":"C E Nugent"}]},{"@id":"https://cir.nii.ac.jp/crid/1381418520826378753","@type":"Researcher","foaf:name":[{"@value":"M Barr"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"10466673"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/10466673"}],"prism:publicationName":[{"@value":"Journal of the American Society of Nephrology"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"1993-03","prism:volume":"3","prism:number":"9","prism:startingPage":"1575","prism:endingPage":"1582"},"reviewed":"false","url":[{"@id":"https://journals.lww.com/00001751-199303000-00006"}],"createdAt":"2021-04-26","modifiedAt":"2023-03-01","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360285706218504704","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"(Pro)renin and (pro)renin receptor expression during kidney development in neonates"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206426760832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Smooth Muscle Cell Proliferation in the Ductus Arteriosus and the Descending Aorta, and Effects of Enalapril on SMC Proliferation in Perinatal Rats."}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679879016448","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Children's toxicology from bench to bed - Drug-induced Renal Injury (1): The toxic effects of ARB/ACEI on fetal kidney development"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681401850496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Enhancement of Neonatal Rat Ductal Responsiveness to Prostaglandin E2 after Maternal Treatment with Enalapril or Captopril."},{"@language":"ja-Kana","@value":"Enhancement of Neonatal Rat Ductal Resp"}]},{"@id":"https://cir.nii.ac.jp/crid/1390851806061940480","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Transplacentally-Administered Enalapril Inhibits the Spontaneous Constriction of the Ductus Arteriosus in the Newborn Rat"},{"@language":"ja-Kana","@value":"Transplacentally Administered Enalapril"},{"@value":"Transplacentally‐Administered Enalapril Inhibits the Spontaneous Constriction of the Ductus Arteriosus in the Newborn Rat"}]},{"@id":"https://cir.nii.ac.jp/crid/2050588892097669760","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Urinary angiotensinogen level is increased in preterm neonates"}]},{"@id":"https://cir.nii.ac.jp/crid/2051433317031776128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Enhanced angiotensinogen expression in neonates during kidney development"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1681/asn.v391575"},{"@type":"CROSSREF","@value":"10.1292/jvms.61.1215_references_DOI_6ZGtbUwQZ6Kow59PSc1gB51sBPM"},{"@type":"CROSSREF","@value":"10.1007/s10157-014-0977-y_references_DOI_6ZGtbUwQZ6Kow59PSc1gB51sBPM"},{"@type":"CROSSREF","@value":"10.1292/jvms.60.989_references_DOI_6ZGtbUwQZ6Kow59PSc1gB51sBPM"},{"@type":"CROSSREF","@value":"10.1007/s10157-018-1662-3_references_DOI_6ZGtbUwQZ6Kow59PSc1gB51sBPM"},{"@type":"CROSSREF","@value":"10.2131/jts.34.sp245_references_DOI_6ZGtbUwQZ6Kow59PSc1gB51sBPM"},{"@type":"CROSSREF","@value":"10.1007/s00431-016-2820-9_references_DOI_6ZGtbUwQZ6Kow59PSc1gB51sBPM"},{"@type":"CROSSREF","@value":"10.1111/j.1741-4520.1994.tb00270.x_references_DOI_6ZGtbUwQZ6Kow59PSc1gB51sBPM"}]}